Canada Markets closed

LexaGene Holdings Inc. (LXXGF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.08060.0000 (0.00%)
At close: 04:59PM EDT

LexaGene Holdings Inc.

500 Cummings Center
Suite 4550
Beverly, MA 01915
United States
800 215 1824

IndustryMedical Devices
Full Time Employees33

Key Executives

NameTitlePayExercisedYear Born
Dr. John F. ReganFounder, Chairman & CEO371.68kN/A1973
Mr. Jeffrey MitchellCFO, Treasurer & Corp. Sec.293.4kN/A1971
Mr. Steven ArmstrongChief Operating Officer234.32kN/A1965
Mr. Allan John FabbroVP of Corp. Devel.N/AN/A1957
Nicole RidgedaleDirector of Corp. MarketingN/AN/AN/A
Mr. Jay AdelaarVP of Capital MarketsN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets; and assay panels. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. LexaGene Holdings Inc. was incorporated in 2007 and is headquartered in Beverly, Massachusetts.

Corporate Governance

LexaGene Holdings Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.